Category: ILA

Education of the general audience is one of four main activities of the ILA. This is why the representatives of the organization are using every opportunity to represent the idea at public events, to make people more informed about the present level of longevity technologies development and to help them become more familiar with the philosophy backing longevity research.

Didier Coeurnelle, Co-chair of Heales (Healthy Life Extension Society), the largest non-profit organization in Continental Europe promoting and advocating scientific research into longevity and biogerontology, Vice-president of the French association AFT-Technoprog and a founding member of the International Longevity Alliance was recently invited to speak at TEDxULB. We invite you to enjoy his speech.

Originally published at ILA.

On December 2nd, the US Food and Drug Administration authorized a five-year test of Metformin  on 3,000 people aged 60 and older. Metformin already allows a dramatic lengthening of life for diabetic patients. The objective of this revolutionary research is to check whether aging in “ordinary” elderly citizens is slowed down with this product (like it is in mice). In other words, the goal is to treat aging as a disease.

The day before, on December 1st, Mark Zuckerberg, celebrating the birth of his daughter, decided to devote most of his fortune, or 43 billion dollars to create (with his wife) a non-profit company. One of the objectives of the company will be to fight against the diseases that remain today. In a letter to his daughter and his few (million) Facebook friends, he writes: “Today we spend about 50 times more as a society treating people who are sick than we invest in research so you won’t get sick in the first place. (…) Can our generation cure disease so you live much longer and healthier lives? ” Continue reading “ILA Press release: Metformin, Zuckerberg and British citizens on the road to longevity”

The World Health Organization launched public consultations on the Global Strategy and Action Plan on Ageing and Health, which will continue until October 30, 2015, and invited NGOs to take part.

Zero draft of the Strategy
English Version
French Version

The Longevity community should take part in these consultations, as this document will have a significant influence on the national policies and resources allocated for research on aging and longevity. Continue reading “ILA position with respect to WHO’s Global Strategy and Action Plan on Ageing and Health”

It has become a tradition to intensify the dialogue about longevity technologies development in September and October, before and after the UN International Day of Older Persons. This year, the ILA representatives organized and visited the events in several countries. Continue reading “ILA celebrates the Day of Older Persons by series of events to support longevity technologies”